Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Types of Depression

Depression Depression and Cardiovascular Disease
June 12, 2025in Depression 0 Comments 0 Likes

Depression and Cardiovascular Disease

Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the

by Dr. Bryan Bruno, Medical Director
Depression Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
May 27, 2025in Depression 0 Comments 0 Likes

Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe

Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading

by Dr. Bryan Bruno, Medical Director
Depression Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
May 4, 2025in Depression 0 Comments 0 Likes

Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants

Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown

by Dr. Bryan Bruno, Medical Director
Depression Can Exercise Treat Depression?
April 18, 2025in Depression 0 Comments 0 Likes

Can Exercise Treat Depression?

Depression: A Growing Global Challenge Depression is one of the world’s leading causes of disability, affecting over 280 million people worldwide. Traditional treatments—such as antidepressants and psychotherapy—help many, but they’re

by Dr. Bryan Bruno, Medical Director
anxiety Antidepressant Weight Gain: A Recent Study
April 15, 2025in anxiety 0 Comments 0 Likes

Antidepressant Weight Gain: A Recent Study

In the landscape of mental health treatment, antidepressant medications play a crucial role in managing conditions like Depression. However, patients and clinicians often express concern about potential side effects, with

by Dr. Bryan Bruno, Medical Director
Depression Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study
April 10, 2025in Depression 0 Comments 0 Likes

Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study

Treatment-resistant Depression (TRD) remains one of Psychiatry’s most complex clinical challenges. Standard antidepressants often fail to bring relief to approximately one-third of patients with Major depressive disorder (MDD). In this

by Dr. Bryan Bruno, Medical Director
Depression A New Era in Mental Health: Ketamine-Based Therapies for Treatment-Resistant Depression
March 20, 2025in Depression 0 Comments 0 Likes

A New Era in Mental Health: Ketamine-Based Therapies for Treatment-Resistant Depression

Depression is not a one-size-fits-all disorder. While many people find relief with traditional antidepressant treatments, approximately 30% of patients diagnosed with major depressive disorder (MDD) fall into the category of treatment-resistant

by Dr. Bryan Bruno, Medical Director
Depression Can Maintenance TMS Prevent Relapse in Depression? The Latest Research
March 11, 2025in Depression 0 Comments 0 Likes

Can Maintenance TMS Prevent Relapse in Depression? The Latest Research

Major Depressive Disorder (MDD) is a complex and often recurrent condition that affects millions of people worldwide. While treatments such as antidepressant medications and psychotherapy have proven effective for many,

by Dr. Bryan Bruno, Medical Director
Depression Standard vs. Accelerated Intermittent Theta Burst Stimulation for Depression: A Recent Study
February 14, 2025in Depression 0 Comments 0 Likes

Standard vs. Accelerated Intermittent Theta Burst Stimulation for Depression: A Recent Study

Major depressive disorder (MDD) is a leading cause of disability worldwide, affecting millions of people each year. While antidepressant medications and psychotherapy are the primary treatments, approximately one-third of patients

by Dr. Bryan Bruno, Medical Director
Depression Lamictal vs. TMS and Esketamine (Spravato) for Treatment-Resistant Depression
February 11, 2025in Depression 0 Comments 0 Likes

Lamictal vs. TMS and Esketamine (Spravato) for Treatment-Resistant Depression

For millions of Americans struggling with Depression that hasn’t responded to traditional antidepressants, finding effective treatment can feel like an endless journey. The impact of persistent Depression can be devastating,

by Dr. Bryan Bruno, Medical Director
Prev

Posts navigation

  • 1
  • 2
Next

Recent Posts

  • Depression and Cardiovascular Disease
  • Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
  • Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
  • Can Exercise Treat Depression?
  • Antidepressant Weight Gain: A Recent Study

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}